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Abstract
Background: The optimal treatment of in-stent restenosis (ISR) has not yet been identified.
The aim of this study was to show the mechanisms of lumen enlargement with cutting balloon
angioplasty in the treatment of ISR by intravascular ultrasound (IVUS).
Material and methods: A total of 40 consecutive patients of mean age 54 ± 10 years, in
whom cutting balloon (CB) angioplasty was applied for ISR treatment, were included in the
investigation. Ultrasonic images were recorded during an automatic pull-back manoeuvre at
a constant speed of 0.5 mm/s. Serial IVUS studies were performed before and after interven-
tion. The external elastic membrane, lumen, neointimal and stent areas were measured at
intervals of 0.5 mm throughout the length of the stent and in the proximal and distal reference
segments (5 mm from the stent edge).
Results: The use of CB led to a significant increase in lumen area and a decrease in the
neointima area (p < 0.05). It was also of note that the mean increase in stent area was
statistically significant. The external elastic membrane and plaque areas did not change
significantly after the procedure (p = NS). Intravascular ultrasound assessment revealed that
cutting balloon angioplasty led to a 29% reduction in the neointimal area. The stent area was
enlarged by 24.9% and the external elastic membrane area increase was 14.2% after comple-
tion of the procedure (p = NS). Plaque areas at both reference segments showed a slight
increase (p = NS).
Conclusions: Treatment of ISR with cutting balloon angioplasty is related to an increase in
the lumen and stent areas, which is associated with neointima extrusion through the stent
struts and axial redistribution of the neointima. (Folia Cardiol. 2005; 12: 493–498)
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Introduction
The widespread use of coronary stents has led
to a specific new “disease”, that of in-stent reste-
nosis (ISR), which is reported with an incidence
ranging from 8.3% to as much as 50% of cases [1, 2].
The main mechanism responsible for its develop-
ment is neointimal formation [3]. So far, different
techniques and approaches have been applied to li-
mit the occurrence of  ISR and several techniques
have been evaluated to improve the artery lumen
of restenotic stents [4]. The most popular techni-
ques for ISR are plain balloon angioplasty, intra-
coronary brachytherapy [5] and cutting balloon an-
gioplasty [6]. The aim of the study therefore was
to show the mechanisms of lumen enlargement with
cutting balloon angioplasty in the treatment of in-
stent restenosis by intravascular ultrasound (IVUS).
Material and methods
Patient selection
For the purposes of the study, we retrospectively
analyzed 40 consecutive patients of mean age 54 ±
± 10 years, in whom cutting balloon (CB) angiopla-
sty was applied for ISR treatment.
Restenostic lesions in vessels with a reference
diameter greater than 2.5 mm were considered for the
study. Patients with either focal (< 10 mm in length)
or diffuse (> 10 mm in length) in-stent restenosis
were included, but patients with a totally occluded
coronary segment were excluded from the study.
Initial stent procedures
The mean interval between initial stent implan-
tation and the CB procedure for ISR treatment was
6 ± 3 months (range 3–12). The mean stent size
was 3.21 ± 0.36 mm and its length was 15.7 ±
± 6.2 mm. The mean inflation pressure used for
stent implantation was 15.4 ± 2.7 atm.
Procedures
Cutting balloon (Boston Scientific, Natick, MA,
USA) is a non-compliant balloon varying from 10 to
15 mm in length with 3 or 4 microblades, depen-
ding on the size of the balloon. In the present study
multiple inflations were performed at a pressure of
up to 10–12 atm. In 16 cases out of 40 (40%) a 10 mm
CB was used and in the remaining patients angio-
plasty was performed with a 15 mm balloon. The
mean size of the CB was 3.55 ± 0.39 mm with
a length of 13.12 ± 2.5 mm.
Intravascular ultrasound studies were perfor-
med both before and after intervention with a com-
mercially available mechanical system (Boston
Scientific Co, Natwitch, MS, USA) using 30 MHz
or 40 MHz imaging catheters (Ultracross and Atlan-
tis). The IVUS was performed in the same mode:
after nitroglycerin administration, the imaging pro-
be was positioned distally to the target lesion and
pulled back at a constant speed of 0.5 mm/s with the
use of a motorised pull-back device. IVUS images
were recorded onto high-resolution s-VHS videota-
pe for off-line analysis.
Quantitative angiographic
and IVUS evaluation
Off-line quantitative coronary angiography
(QCA) analyses were performed at the European
Imaging Laboratory by 2 technicians, who were
unaware of the IVUS measurements. Angiographic
measurements were performed with a computer-
assisted system using an automated edge detection
algorithm (MEDIS Co, Eindhoven, Netherlands)
with a dye-filled guiding catheter for calibration.
Intravascular ultrasound recordings were ana-
lysed for every second of videotape using commer-
cially available software (Tape Measure, INDEC
Co.). During the analysis each coronary segment
was axially divided into several 0.5 mm segments.
Data from the analysis was presented as means
and for the stented region included the minimal lu-
men area (LA), the total vessel area bordered by the
external elastic membrane (EEM), the stent area
(SA), the neointimal area (NA) defined as the echo-
genic material within the stent and the calculated SA
minus the LA and plaque area (PA) measured as the
plaque and media area between the EEM and the stent
borders. The differences between procedural steps
were calculated in the mean lumen areas, EEM, stent,
neointimal and plaque areas. The analysis also encom-
passed two 5 mm reference segments in which lumen,
EEM and PA were calculated.
The reproducibility of the IVUS and QCA me-
asurements performed at the European Imaging
Laboratory has already been reported [7, 8].
Statistical analysis
Continuous variables are expressed as mean ±
± standard deviation (SD) values. A two-tailed  t test
was used for the continuous variables. Linear re-
gression analyses were performed to compare the
study data. A value of p < 0.05 was considered sta-
tistically significant.
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Results
The demographic, clinical and angiographic
characteristics and the procedural data are presen-
ted in Tables 1 and 2. Pre-interventional IVUS as-
sessment showed a diffuse pattern of ISR in 64%
of cases.
Table 3 refers to the IVUS results obtained
before and after intervention. The use of CB led to
a significant increase in lumen area and a decrease
in neointima area (p < 0.05). It is also of note that
the mean increase in stent area was statistically
significant. The EEM and plaque areas did not chan-
ge significantly after the procedure (p = NS)
Intravascular ultrasound assessment revealed
that cutting balloon angioplasty led to a 29% reduc-
tion in the neointimal area. The stent area enlarged
by 24.9% and the EEM area increase was 14.2% after
procedure completion (p = NS). It was notable that
lumen improvement (increase) was only 53% (Fig. 1).
Figure 2 refers to the mean neointima area
decrease in two subsets of patients, those with and
Table 1. Patient population (n = 40)
Tabela 1. Charakterystyka kliniczna pacjentów
Age (years) 54 ± 10
Male 89.2%
Diabetes 10.7%
Smoking 50.0%
Previous myocardial infarction 45.7%
Vessel treated
   left anterior descending artery  28 (70%)
   left circumflex artery 3 (7.5%)
   right coronary artery 9 (22.5%)
Table 2. Angiographic and procedural
characteristics
Tabela 2. Dane angiograficzne i proceduralne
QCA measurements pre treatment
   MLD [mm] 0.9 ± 0.25
   Ref. D. [mm] 2.88 ± 0.36
   %DS (%) 68.7 ± 14.5
   Lesion length [mm] 12.3 ± 4.1
QCA measurements post treatment
   MLD [mm] 2.48 ± 0.55
   Ref. D. [mm] 3.01 ± 0.44
   %DS (%) 17.6 ± 10.1
Acute gain [mm] 1.58 ± 0.67
BA/artery ratio 1.22 ± 0.24
Inflation pressure [atm] 8.5 ± 2.1
Table 3. Intravascular ultrasound results from
the treated segment (n = 40)
Tabela 3. Wyniki ultrasonografii wewnątrz-
wieńcowej w badanych segmentach naczyń
Distal reference segment
   EEM area pre [mm2] 10.42 ± 4.36
   EEM area post [mm2] 10.93 ± 4.36
   LA area pre [mm2] 5.04 ± 1.96
   LA area post [mm2] 4.57 ± 1.97
   PA area pre [mm2] 5.38 ± 3.06
   PA area post [mm2] 6.36 ± 3.00
Restenotic lesion
   EEM area pre [mm2] 16.42 ± 5.57
   EEM area post [mm2] 18.76 ± 5.84
   LA area pre [mm2] 4.11 ± 1.37
   LA area post [mm2] 6.31 ± 2.02*
   SA area pre [mm2] 7.93 ± 2.40
   SA area post [mm2]  9.91 ± 3.01*
   PA area pre [mm2] 8.42 ± 3.43
   PA area post [mm2]  8.83 ± 3.32
   NA area pre [mm2] 4.27 ± 1.96
   NA area post [mm2] 3.31 ± 1.42*
Proximal reference segment
   EEM area pre [mm2] 16.28 ± 6.45
   EEM area post [mm2] 16.82 ± 6.64
   LA area pre [mm2] 7.35 ± 2.95
   LA area post [mm2] 7.15 ± 2.75
   PA area pre [mm2] 8.92 ± 4.75
   PA area post [mm2] 9.66 ± 4.88
*p < 0.05 pre vs. post; EEM — external elastic membrane; LA — lumen
area; PA — plaque area; SA — stent area
those without a mean IVUS stent area of 9.0 mm2
(using the MUSIC trial criteria). The neointima de-
crease was larger in patients with a mean stent area
of over 9.0 mm2 but the difference was not significant.
Reference segment analysis
Introvascular ultrasound analysis obtained in the
reference segments revealed that there was
a trend to lumen area decrease and plaque area incre-
ase. The percentage of PA increase was 18.2% in the
distal reference segment and 8.2% in the proximal
reference segment.
Discussion
The major findings of the present study are that
the main mechanism of lumen enlargement with CB
angioplasty consists of an increase in the lumen and
stent areas which is related to neointima extrusion
through the stent struts and its axial redistribution.
Uncontrolled arterial smooth muscle prolifera-
tion is mainly responsible for the development of
ISR [3, 9]. Several systemic, angiographic and IVUS
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factors have been proposed as predictors of ISR [10].
So far, no optimal treatment of ISR has been deve-
loped, although some approaches are used in clini-
cal practice such as POBA, debulking techniques
(rotablation or DCA) and cutting balloon angiopla-
sty, excimer laser angioplasty or stenting, recently
with drug eluting stents [10]. Of course, the most
popular method for ISR treatment is simple balloon
inflation, alternatively with CB, which provides a bet-
ter angiographic and clinical outcome than POBA [4].
Previous studies concerning the mechanisms
of lumen enlargement after ISR treatment have led
to a different observation, especially in the case of CB.
Ahmed et al. [11] showed that the main mechani-
sms of lumen enlargement with CB are related to
neointima extrusion through the stent struts and
its axial redistribution into reference segments, as
reported in our study. On the other hand, Muramatsu
et al. [12] concluded that CB inflation led to
a decrease in plaque area with a constant stent and
EEM area. In this study both EEM and stent area in-
crease and, furthermore, axial neointima redistribu-
tion were demonstrated as playing a significant role
in lumen enlargement. The stent area increased by
24.9%, more than in the previous study by Kinoshita
et al. [13], who obtained only a 10.6% stent increase.
However, it should be remembered that CB is a non-
compliant balloon, designed for this kind of work.
Prompter selection of CB size and its relation to the
artery may play a crucial role in the acute results of
CB angioplasty. The use of a BA/artery ratio greater
then 1.0 may help to achieve more gain in lumen.
On the basis of the results of present and pre-
vious studies [11, 15], the possibility cannot be exc-
Figure 2. A comparison of the neointima area change obta-
ined in patients with a mean stent area > 9.0 mm2 (large
stents) with patients with a mean stent area < 9.0 mm2
(small stents)
Rycina 2. Porównanie zmiany pola neointimy u pacjen-
tów ze średnim polem światła stentu powyżej 9,00 mm2
(„duże stenty”) z chorymi ze średnim polem światła
stentu poniżej 9,00 mm2 („małe stenty”)
Figure 1. Example of the procedure performed in studied group
Rycina 1. Przykład zabiegu wykonanego w badanej populacji
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Streszczenie
Wstęp: Obecnie nie ma optymalnego sposobu leczenia restenozy w stencie. Celem poniższej
pracy jest ultrasonograficzna ocena mechanizmów powiększenia światła naczynia po zabiegu
angioplastyki balonem tnącym (CB) u chorych z restenozą w stencie.
Materiał i metody: Do badania włączono 40 (średni wiek 54 ± 10 lat) kolejnych chorych
z restenozą w stencie, u których do leczenia użyto balonu tnącego. Badanie metodą ultrasono-
grafii wewnątrzwieńcowej (IVUS) wykonywano zarówno przed interwencją, jak i po niej,
używając automatycznego przesuwu sondy przy stałej prędkości 0,5 mm/s. Do analizy włączo-
no pole całkowite naczynia, pole światła naczynia, pole blaszki miażdżycowej, pole neointimy
i pole światła stentu, które zostały zmierzone co 0,5 mm na całej długości stentu oraz w obrębie
5 mm segmentów referencyjnych naczynia.
Wyniki: Stwierdzono, że użycie CB prowadzi do istotnego przyrostu pola światła naczynia
i istotnej redukcji neointimy (p < 0,05). Ponadto, zaobserwowano istotny przyrost pola stentu
(p < 0,05). Całkowite pole naczynia oraz pole blaszki miażdżycowej nie zmieniły się istotnie po
zabiegu (p = NS). Zastosowanie IVUS pokazało, że angioplastyka CB prowadzi do 29-procen-
towej redukcji neointimy, 24,9-procentowego zwiększenia pola stentu oraz 14,2-procentowego
przyrostu całkowitego pola naczynia. Analiza zmian w segmentach referencyjnych ujawniła
trend w kierunku przyrostu blaszki, który nie był istotny statystycznie.
Wnioski: Angioplastyka balonem tnącym prowadzi do istotnego przyrostu pola światła naczy-
nia oraz zwiększenia pola stentu, co wiąże się z przemieszczeniem neointimy pomiędzy elemen-
ty stentu i w kierunku segmentów referencyjnych. (Folia Cardiol. 2005; 12: 493–498)
restenoza w stencie, ultrasonografia wewnątrzwieńcowa, angioplastyka
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